DOCSLIB.ORG

Document Breaches Copyright Please Contact Us Providing Details, and We Will Remove Access to the Work Immediately and Investigate Your Claim

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Document Breaches Copyright Please Contact Us Providing Details, and We Will Remove Access to the Work Immediately and Investigate Your Claim Vrije Universiteit Brussel Supportieve zorg bij de behandeling met immuuncheckpointinhibitoren Awada, Gil; Rogiers, Anne Irène; Neyns, Bart Published in: OncoHemato Publication date: 2019 Link to publication Citation for published version (APA): Awada, G., Rogiers, A. I., & Neyns, B. (2019). Supportieve zorg bij de behandeling met immuuncheckpointinhibitoren. OncoHemato, 12(7), 39-50. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 09. Oct. 2021 VOL 12 Nr 7 DECEMBER 2018- JANUARI 2019 - 6x/jaar Afgiftekantoor - Charleroi X - P801027 Onco hemato MULTID ISC IPL INAIR T IJDSCHRIFT VOOR ONCOLO GIE EN HEMATOLOGIE www.oncohemato.be Burn-out bij Belgische arts-specialisten in opleiding Ruben Willems, Chris Monten, Gwendolyn Portzky Supportieve zorg bij de behandeling met immuuncheckpointinhibitoren Gil Awada, Anne Rogiers, Bart Neyns Late Breaking Abstracts op het ASH-congres Dominique-Jean Bouilliez ONCO_12_7_N_2018 REGIMEN Leading the Way in Immuno-Oncology Verantwoordelijke uitgever: V. Leclercq - Varenslaan 6 - 1950 Kraainem - Varenslaan Leclercq uitgever: V. Verantwoordelijke 1506BE18PR01355 03/2018 ISSN 2030-2738 ISSN 2030-272X OPDI 6685 Pavé_80x80 1.3.indd 2 13/03/18 14:57 This product is not yet marketed BEHIND KANJINTI® AMGEN’S EXPERTISE DELIVERS CONFIDENCE AND RELIABILITY KANJINTI® The trastuzumab biosimilar by Amgen Discover Amgen Biosimilars via https://www.amgenbiosimilars.be KANJINTI® is the trastuzumab biosimilar by Amgen indicated for the treatment of HER2-positive metastatic breast cancer, HER2-positive early breast cancer and HER2-positive metastatic adenocarcinoma of the stomach or gastroesophageal junction, all in adult patients.1 HER2 = human epidermal growth factor receptor 2. 1. KANJINTI Summary of Product Characteristics. Latest version. R.E. Amgen nv, Telecomlaan 5-7, 1831 Diegem - BL-P-BIO-0718-066071(1) - Creation date: November, 2018 KANJINTI® powder for concentrate for solution for infusion ▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1. NAME OF THE MEDICINAL PRODUCT: KANJINTI whom an anthracycline is not suitable. In combination initiation of therapy (see sections 4.4 and 5.1). KANJINTI 150 mg and 420 mg powder for concentrate for with docetaxel for the treatment of those patients who treatment should only be initiated by a physician solution for infusion. 2. QUALITATIVE AND have not received chemotherapy for their metastatic experienced in the administration of cytotoxic QUANTITATIVE COMPOSITION: KANJINTI 150 mg disease. In combination with an aromatase inhibitor for chemotherapy (see section 4.4), and should be powder for concentrate for solution for infusion: One the treatment of postmenopausal patients with administered by a healthcare professional only. vial contains 150 mg of trastuzumab, a humanised IgG1 hormone-receptor positive MBC, not previously treated KANJINTI intravenous formulation is not intended for monoclonal antibody produced by mammalian with trastuzumab. Early breast cancer: KANJINTI is subcutaneous administration and should be (Chinese hamster ovary) cell suspension culture and indicated for the treatment of adult patients with HER2 administered via an intravenous infusion only. In order purifi ed by affi nity and ion exchange chromatography positive early breast cancer (EBC): Following surgery, to prevent medication errors it is important to check the including specifi c viral inactivation and removal chemotherapy (neoadjuvant or adjuvant) and vial labels to ensure that the medicinal product being procedures. KANJINTI 420 mg powder for concentrate radiotherapy (if applicable) (see section 5.1). Following prepared and administered is KANJINTI (trastuzumab) for solution for infusion: One vial contains 420 mg of adjuvant chemotherapy with doxorubicin and and not trastuzumab emtansine. Posology: Metastatic trastuzumab, a humanised IgG1 monoclonal antibody cyclophosphamide, in combination with paclitaxel or breast cancer: Three-weekly schedule: The produced by mammalian (Chinese hamster ovary) cell docetaxel. In combination with adjuvant chemotherapy recommended initial loading dose is 8 mg/kg body suspension culture and purifi ed by affi nity and ion consisting of docetaxel and carboplatin. In combination weight. The recommended maintenance dose at exchange chromatography including specifi c viral with neoadjuvant chemotherapy followed by adjuvant threeweekly intervals is 6 mg/kg body weight, inactivation and removal procedures. The reconstituted KANJINTI therapy, for locally advanced (including beginning three weeks after the loading dose. Weekly KANJINTI solution contains 21 mg/mL of trastuzumab. infl ammatory) disease or tumours > 2 cm in diameter schedule: The recommended initial loading dose of For the full list of excipients, see section 6.1. 3. (see sections 4.4 and 5.1). KANJINTI should only be KANJINTI is 4 mg/kg body weight. The recommended PHARMACEUTICAL FORM: Powder for concentrate used in patients with metastatic or early breast cancer weekly maintenance dose of KANJINTI is 2 mg/kg for solution for infusion. White to pale yellow lyophilised whose tumours have either HER2 overexpression or body weight, beginning one week after the loading powder. 4. CLINICAL PARTICULARS: 4.1 Therapeutic HER2 gene amplifi cation as determined by an accurate dose. Administration in combination with paclitaxel or indications: Breast cancer: Metastatic breast cancer: and validated assay (see sections 4.4 and 5.1). Metastatic docetaxel: In the pivotal trials (H0648g, M77001), KANJINTI is indicated for the treatment of adult gastric cancer: KANJINTI in combination with paclitaxel or docetaxel was administered the day patients with HER2 positive metastatic breast cancer capecitabine or 5-fl uorouracil and cisplatin is indicated following the fi rst dose of trastuzumab (for dose, see (MBC): As monotherapy for the treatment of those for the treatment of adult patients with HER2 positive the Summary of Product Characteristics (SmPC) for patients who have received at least two chemotherapy metastatic adenocarcinoma of the stomach or paclitaxel or docetaxel) and immediately after the regimens for their metastatic disease. Prior gastroesophageal junction who have not received prior subsequent doses of trastuzumab if the preceding chemotherapy must have included at least an anti-cancer treatment for their metastatic disease. dose of trastuzumab was well tolerated. Administration anthracycline and a taxane unless patients are KANJINTI should only be used in patients with in combination with an aromatase inhibitor: In the unsuitable for these treatments. Hormone-receptor metastatic gastric cancer (MGC) whose tumours have pivotal trial (BO16216) trastuzumab and anastrozole positive patients must also have failed hormonal HER2 overexpression as defi ned by IHC 2+ and a were administered from day 1. There were no restrictions therapy, unless patients are unsuitable for these confi rmatory SISH or FISH result, or by an IHC 3+ result. on the relative timing of trastuzumab and anastrozole treatments. In combination with paclitaxel for the Accurate and validated assay methods should be used at administration (for dose, see the SmPC for treatment of those patients who have not received (see sections 4.4 and 5.1). 4.2 Posology and method of anastrozole or other aromatase inhibitors). Early breast chemotherapy for their metastatic disease and for administration: HER2 testing is mandatory prior to cancer: Threeweekly and weekly schedule: As a AMG-Kanjinti-Journal Ad (SH 100102).indd 1 23/11/18 09:41 threeweekly regimen the recommended initial loading infestations: Very common: Infection, Nasopharyngitis; symptomatic and asymptomatic left ventricular dose of KANJINTI is 8 mg/kg body weight. The Common: Neutropenic sepsis, Cystitis, Herpes zoster, dysfunction was 4.6%. Reversibility of severe CHF recommended maintenance dose of KANJINTI at Influenza, Sinusitis, Skin infection, Rhinitis, Upper (defined as a sequence of at least two consecutive three-weekly intervals is 6 mg/kg body weight, respiratory tract infection, Urinary tract infection, LVEF values ≥ 50% after the event) was evident for beginning three weeks after the loading dose. As a Erysipelas, Cellulitis, Pharyngitis; Uncommon: Sepsis. 71.4% of trastuzumab-treated patients. Reversibility of weekly regimen (initial loading dose of 4 mg/kg Neoplasms benign, malignant and unspecified (incl. mild symptomatic and asymptomatic left ventricular followed by 2 mg/kg every week) concomitantly with Cysts and polyps): Not known: Malignant neoplasm dysfunction was demonstrated for 79.5% of patients. paclitaxel
Load more

Recommended publications
  • Les Van Den Ghein Fondeurs De Cloches, Canons, Sonnettes Et Mortiers, À Malines Dr. G. Van Doorslaer
    Les van den Ghein fondeurs de cloches, canons, sonnettes et mortiers, à Malines by Dr. G. Van Doorslaer (English Translation) File-01 – Pages 1 to 99 This document is provided for you by The Whiting Society of Ringers visit www.whitingsociety.org.uk for the full range of publications and articles about bells and change ringing Dr. G. VAN DOORSLAER FULL MEMBER THE ROYAL ACADEMY OF ARCHEOLOGY OF BELGIUM The van den Ghein founders of bells, cannons, handbells and mortars in Mechelen. Extract from the annals of the Royal Academy of Archaeology of Belgium ANTWERP 1910 ENGLISH TRANSLATION John Martin 2019 2 NOTES ABOUT THIS TRANSLATION The page numbers and formatting of the original printed book have been preserved, starting at Page 3, so that citations remain correct. Van Doorslaer used French versions of proper names (e.g. he used Jean rather than Jan, Pierre rather than Peter, and Malines rather than Mechelen.) This translation has reverted to the original Flemish names in the body text. These are the names that appear on the bells. However, the Annexes are left untranslated, following van Doorslaer’s example, so these maintain the French versions of proper names where Doorslaer himself writes, and the original Flemish names when source documents are quoted verbatim. Illustrations are scanned from the original printed book. Any text in brown (like this) is not part of the original book, but added by the translator. I am grateful to my friends Penny Granger and David McClean for their help with Dutch and Latin, and to the Whiting Society for kindly hosting this work on their website.
    [Show full text]
  • RADICAAL VOOR RECHTEN Teksten Europees Forum Over Rechten En Vrijheden in Tijden Van Toenemende Polarisering
    RADICAAL VOOR RECHTEN Teksten Europees Forum over rechten en vrijheden in tijden van toenemende polarisering. OP.RECHT.MECHELEN. 26-27 april 2017 Gie Goris (editor), Navi Pillay, Pankaj Mishra, Geert Mak, Bart Somers, Irene Khan, Rachida Lamrabet, Catherine Woollard, Assita Kanko, Barbara Oomen, Pascal Debruyne, Nadim Houry, Peter Knoope, Aya Sabi, Orlando Verde, Bie Vancraeynest, Julie Reniers INHOUD 4 Het onderwerp beweegt terwijl we erop proberen focussen Gie Goris 11 I. 69 II. 12 Universele rechten en burgerlijke vrijheden 70 Inclusieve rechten, in woedende tijden exclusieve samenlevingen? 14 Navi Pillay : ‘Wie mensenrechten verwaarloost, 72 Promoting the universality and krijgt af te rekenen met veel groter geweld’ indivisibility of human rights is the path Gie Goris to inclusive societies 22 States have an obligation to respect, Irene Khan protect and fulfill the human rights of all 79 De ethische ontregeling van de wereld individuals under their jurisdiction Rachida Lamrabet Navi Pillay 88 Inclusieve rechten, exclusieve samen- 28 Pankaj Mishra: ‘Frustratie en politiek verzet levingen: wij zijn de bouwstenen voor ontstaan als mensen het gevoel krijgen verandering dat er méér in hun leven zit’ Aya Sabi Gie Goris 98 Het recht om rechten te hebben 40 We need a radically enlarged understanding 100 The impact of “the refugee crisis”: of what it means for human beings to pursue rights are at risk in Europe the contradictory ideals of freedom, Catherine Woollard equality and prosperity 104 Alle mannen worden vrij geboren. Pankaj Mishra
    [Show full text]
  • VOL.L. BELGIUM I MANAGEMENT of the COMMUNITY CRISIS
    VOL.l. BELGIUM I MANAGEMENT OF THE COMMUNITY CRISIS 1961-1981 by J.G.WARDEN Thesis for the Degree of Ph.D. 1985. UMI Number: U000253 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Disscrrlation Publishing UMI U000253 Published by ProQuest LLC 2015. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 CONTENTS Page VOLUME 1 CHAPTER 1; CONSOCIATIONAL DEMOCRACY IN BELGIUM - the nature of the political system before 1961 and the relevance of the consoclatlonal model. CHAPTER 2; CRISIS MANAGEMENT IN BELGIUM - the application of the consoclatlonal approach In the 1950s and in face of the Community Crisis of the 1960s and 1970s. 47 CHAPTER 3; THE FLEMISH MOVEMENT IN THE 1960s - the collective assertion of the demands of the Flemish *volk* in the Belgian state as a whole and Brussels in particular. 86 CHAPTER 4 ; THE WALLOON MOVEMENT OF THE 1960s - the Walloon response to fears of 'minorisation*. 139 CHAPTER 5 ; THE BRUSSELS PROBLEM - the problem of a leurgely French-speaücing capital of a largely Dutch-speaking state. 180 VOLUME 2 CHAPTER 6 ; POLITICAL TRANSFORMATION 1961-71 - the end of the total dominance of the three traditional parties.
    [Show full text]
  • 2E Citta Urban Trail Run Antwerpen
    2e CittA Urban Trail Run Antwerpen - 16 maart 2014 12 KM PL NR Naam Woonplaats Age CAT P/CAT Tijd GEM KM-Tijd 1 6217 VANDEKERCKHOVE Bram GENT 31 SEH 1 0:38:36 18,65 3:13 2 5681 TROGH Ramses AMSTERDAM 37 M35 1 0:39:50 18,08 3:19 3 5437 DE SMET Raf ANTWERPEN 40 M40 1 0:40:27 17,80 3:22 4 77 DE BACKER Kristof ANTWERPEN 31 SEH 2 0:41:43 17,26 3:29 5 8182 BRUYNS Guy BRASSCHAAT 47 M45 1 0:41:56 17,17 3:30 6 53 DE PRETER Sibren PUTTE 23 SEH 3 0:41:56 17,17 3:30 7 7106 VOGELS Bram SCHILDE 16 SEH 4 0:41:57 17,16 3:30 8 5991 SWINNEN Kristof SINT-NIKLAAS 45 M45 2 0:42:14 17,05 3:31 9 3569 VAN GENECHTEN Rudi EDEGEM 56 M55 1 0:42:37 16,89 3:33 10 58 VAN DAELE Tim BURCHT 34 SEH 5 0:43:13 16,66 3:36 11 191 AERTS Erwin WOMMELGEM 49 M45 3 0:43:20 16,62 3:37 12 256 VANDENBOSCH Didier RHODE ST GENÈSE 48 M45 4 0:43:25 16,58 3:37 13 86 GEERTS Pascal DEURNE 49 M45 5 0:43:30 16,55 3:38 14 199 DE MEY Liam DOEL 32 SEH 6 0:43:40 16,49 3:38 15 3420 HERTOGS Guido SCHOTEN 47 M45 6 0:44:06 16,33 3:41 16 129 SABBE Dries NIEL 25 SEH 7 0:44:08 16,31 3:41 17 6152 CLAESSENS Philippe BRUSSEL 30 SEH 8 0:44:20 16,24 3:42 18 141 AERTS Marnik WOMMELGEM 19 SEH 9 0:44:36 16,14 3:43 19 1562 VERCAMMEN Dries PETIT-LANCY 28 SEH 10 0:44:48 16,07 3:44 20 152 HEIJKERS Eugène EINDHOVEN 38 M35 2 0:44:48 16,07 3:44 21 242 BOONEN Laurens DUFFEL 21 SEH 11 0:44:48 16,07 3:44 22 264 SACRÉ Pieter GENT 33 SEH 12 0:44:52 16,05 3:44 23 249 BOUDOUDOUH Hassan ANTWERPEN 31 SEH 13 0:44:57 16,02 3:45 24 377 VAN OERS Tom DEURNE 29 SEH 14 0:44:58 16,01 3:45 25 7477 JORIS Maarten LOENHOUT 35 M35 3 0:44:58
    [Show full text]
  • Deelrapport 1: the Sharing Personality: Kwalitatief Onderzoek O.B.V
    Deelrapport 1: The Sharing Personality: kwalitatief onderzoek o.b.v. deskresearch en interviews bij 11 gebruikers of platformeigenaars en bij 3 niet-gebruikers van dergelijke platformen. Auteurs: Vicky Franssen, Christel De Maeyer, Karijn Bonne & Nicky Malfliet Arteveldehogeschool Gent – 31/08/2017 Dit PWO werd gefinancieerd en ondersteund door de dienst Onderzoek & Dienstverlening aan de Arteveldehogeschool, Gent (PID 001003). De onderzoekers zijn verbonden aan de opleidingen Bachelor Bedrijfsmanagement en Bachelor Grafische en Digitale Media 1 PWO The Sharing Personality – 2016-2017 – Arteveldehogeschool Gent – Rapport 1 Dankwoord Graag willen we in dit voorwoord onze dank richten aan de organisaties die ons in staat gesteld hebben om dit onderzoek te verwezenlijken. Eerst en vooral wensen we het bestuur van de Arteveldehogeschool te bedanken voor de kans die we kregen met dit PWO 2016-2017 (projectcode PID001003). Ten tweede, bedanken we de leden van de begeleidingscommissie voor hun waardevolle suggesties en constructieve bijdragen: dr. Rogier Delanghe (economiefilosoof UGent en beheerder van de Facebookpagina ‘digitale revolutie: peer-to-peer, deeleconomie, collaborative commons’); Valerie Deprycker (medewerker bij Stad Gent); Dries De Roeck (ontwikkelaar en bedenker Popbike van Apps for Ghent); Greet De Wulf (zaakvoerder AgainAgain); Bram Dubois (platformeigenaar RentMyBike); Veronique Leuntjens, Ivo Van Dievoort en Gunther Van den Bossche (bezielers en platformeigenaars JoinUs2Eat); Sebastiaan Schillebeeckx (platformeigenaar
    [Show full text]
  • Geschiedenis 11 (2016) 2
    INHOUD Stadsgeschiedenis 11 (2016) 2 Manon van der Heijden en Jan Hein Furnée In Memoriam: Pim Kooij (1945-2016), stadshistoricus 121 Ellen Janssens Paarden en de moderne stad. De Antwerpse paardeneconomie 123 en het stedelijk leefmilieu (1870-1910) Karla Vanraepenbusch en Matthias Meirlaen Van trauma sites naar herinneringsplekken. De integratie van de 146 executies en de gefusilleerden in de stedelijke ruimte van Antwerpen, Luik en Rijsel (1914-1940) Werk in uitvoering Gemma Blok STADS Heroïne en de stad. Een onderzoek naar de relatie tussen 165 stedelijke omgeving en drugsgebruik Dossier: Gouden boeken Jelle Haemers geschiedenis Gouden boeken? Twee nieuwe syntheses over de laat- 177 middeleeuwse en vroegmoderne stadsgeschiedenis van de Lage Landen Maarten Prak Gouden eeuwen, gouden tijden. De Lage Landen in de 182 middeleeuwen nummer 2 e Arie van Steensel 11 jaargang - 2016 STADSGESCHIEDENIS STADSGESCHIEDENIS 11-2016- Gouden tijden voor de stadsgeschiedenis 187 Reviews Ilja Van Damme, Andrea Bardyn, Bruno Blondé, Heidi Deneweth en Peter Stabel Schetsen uit Finland. De ‘herinterpretatie’ van de stad op het 193 dertiende Internationaal Congres van de European Association for Urban History in Helsinki Petra Brouwer, Heidi Deneweth, Jan Hein Furnée, Maartje van Gelder, Manon van der Heijden en Sanne Muurling Stadsgeschiedenis in buitenlandse tijdschriften (2015) 212 Abstracts 247 Personalia 248 issn 1872-0676 STADS 2 geschiedenis Stadsgeschiedenis is een initiatief van het Centrum voor Stadsgeschiedenis van het Stadsgeschiedenis departement Geschiedenis aan de Universiteit Antwerpen. Het wordt uitgegeven door Een platform voor reflectie op de geschiedenis van de sta Uitgeverij Verloren, Hilversum en verschijnt twee keer per jaar. Stadsgeschiedenis (opgericht in 2006) is het Nederlands-Vlaamse tijdschrift voor Redactiesecretariaat: on derzoek, reflectie en debat over de stad en haar geschiedenis.
    [Show full text]
  • Dertig Jaar Afdeling Agrarische Geschiedenis
    A/L-y its') A.A.G.BIJDRAGE N2 8 DERTIG JAAR AFDELING AGRARISCHE GESCHIEDENIS 1*>L (r?l^ AFDELING AGRARISCHE GESCHIEDENIS LANDBOUWHOGESCHOOL -WAGENINGEN 1986 A.A.G. Bijdragen ISSN 0511-0726 INHOUD A.M. VAN DER WOUDE Dertig jaar Afdeling Agrarische Geschiedenis (with summary: Thirtyyears Departmentof Rural History) 1 O.W.A. BOONSTRA Over computers, cartografie en de expliciteringsplicht bij kwanti­ tatief historisch onderzoek (with summary: Oncomputers, cartograp­ hies andthe burden ofexplicitation in quantitative historical research) 43 R. Bos, G. VAN DIJK, C. KRUYT and H.K. ROESSINGH Long Waves in Economic Development 57 J.L. VAN ZANDEN De telling van de veestapel en de graanproduktie in Zwollerker- spel in 1526. Een stukje van een legpuzzel (with summary:Census oflivestock andcereal production in£wollerkerspel in1526) 93 C.BAARS De geschiedenis van het grondbezit van Gelderse en Utrechtse edelen in de Beijerlanden (with summary: The historyof the landed property andthe nobility of Gelderlandand Utrechtin the Beijerlands) 109 J. BlELEMAN Produktie en consumptie van akkerbouwgewassen in Drenthe aan het begin van de 19e eeuw (with summary: Production andconsump­ tion ofarable products in theprovince ofDrenthe 1811-1813) 145 FRANK DAELEMANS Pachten en welvaart op het platteland van Belgisch Brabant (15de-18de eeuw) (with summary: Lease rents andprosperity in the Belgium countryside: Brabantfrom the15th to the 18thcentury) 165 ROBERT S. DUPLESSIS Capital and Finance in the Early Modern Veluwe Paper Industry 185 BOUDIEN DE VRIES Amsterdamse vermogens en vermogenbezitters, 1855-1875 (with summary: Wealth andthe wealthyin Amsterdam, 1855-1875) 199 A.J. SCHUURMAN Het bezit van preciosa in de Zaanstreek rond 1860. Een recon­ structie van leefstijlen (with summary: The possessionof valuables inthe ^aanstreek about1860: a reconstruction oflife-styles) 217 W.J.M.J.
    [Show full text]